Tech Company Financing Transactions
OcuCure Therapeutics Funding Round
On 10/7/2015, OcuCure Therapeutics landed $200 thousand in financing from private investors.
Transaction Overview
Company Name
Announced On
10/7/2015
Transaction Type
Venture Equity
Amount
$200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15 E. Salem Ave. 201
Roanoke, VA 24011
USA
Roanoke, VA 24011
USA
Phone
Website
Email Address
Overview
OcuCure Therapeutics, Inc. is an ophthalmic pharmaceutical company developing new proprietary drugs. The company's lead compound has been formulated as a topical eye drop for both Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). AMD and DR are leading causes of blindness in developed countries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sunder Malkani
Chief Medical Officer
Craig Greven
Chief Scientific Officer
Patricia Williams
Browse more venture capital transactions:
Prev: 10/7/2015: BioTrackTHC venture capital transaction
Next: 10/7/2015: Code42 venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs